ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.
Syncom Formulations (India) Limited informed exchanges about the dispatch of letters to shareholders with unregistered email addresses, providing instructions to access the 38th AGM Notice and Annual Report.
Syncom Formulations (India) Limited issued notice for its 38th Annual General Meeting, scheduled for 30th September 2026 via Video Conferencing.
Syncom Formulations (India) Limited has filed its 38th Annual Report for the financial year 2025-26, which includes the Notice for the upcoming Annual General Meeting.
Syncom Formulation (India) Ltd reported revenue from operations of ₹125.5 Cr (+7.4% YoY) and net profit of ₹24.8 Cr (+57.0% YoY) for Q1 FY27.
Syncom Formulation (India) Ltd reported revenue from operations of ₹135.4 Cr (-9.1% YoY) and net profit of ₹25.2 Cr (+42.4% YoY) for Q4 FY26.